MedTrace Logo

Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer

NCT01647425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 385

Last updated 2026-03-16

No results posted yet for this study

Summary

This is an multicenter study for preventive and therapeutic strategies for patients with head and neck cancer

Conditions

Interventions

BEHAVIORAL

physician assessment

* Socio-economic conditions and general features: educational level, professional status... * Assessment of current and past use of tobacco: current smoking status reported by the patient; in lifelong non-smokers: previous history of passive smoking reported by the patient; breath carbon monoxide level; in past smokers: age of first cigarette, total reported duration of active smoking, breath carbon monoxide level... * in current smokers: age of first tobacco use, total reported duration of active smoking; Fagerström Nicotine Dependence Test... * Assessment of the current and past uses of alcohol: previous-year assessment using the CAGE questionnaire and the AUDIT Test; average weekly alcohol consumption over the last 12 months... * Assessment of current use of cannabis using the Cannabis Abuse Screening Test * Psychiatric assessment using the MINI 5.0

Sponsors & Collaborators

  • Centre Régional de Référence en Cancérologie

    collaborator OTHER

  • National Cancer Institute, France

    collaborator OTHER_GOV

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Corinne VANNIMENUS, MD · Centre Hospitalier Régional et Universitaire LILLE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-09-30
Completion
2014-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01647425 on ClinicalTrials.gov